We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
MAXIMUS (MMS) Beats on Q2 Earnings, Narrows 2019 Guidance
Read MoreHide Full Article
MAXIMUS, Inc. (MMS - Free Report) reported mixed second-quarter fiscal 2019 results, with earnings beating the Zacks Consensus Estimate but revenues lagging the same.
Earnings per share came in at $1.07 compared with 82 cents reported in the year-ago quarter. The bottom line beat the consensus mark by 15 cents and was benefited by strong performance of the U.S. Health and Human Services, and U.S. Federal Services Segments.
Revenues of $736.5 million missed the consensus mark by $30 million but improved 20% year over year, mainly driven by the acquisition of citizen engagement centers in the U.S. Federal Services Segment.
At the call, management stated that the company continues to execute on its three-pronged strategy of digital transformation, clinical evolution and market expansion.
MAXIMUS shares have gained 12% year to date, significantly underperforming the 25.3% rally of the industry it belongs to.
Revenues by Segment
U.S. Health and Human Services segment revenues of $290.7 million decreased 5% year over year mainly due to the rebid or extension of certain larger contracts in the portfolio.
U.S. Federal Services segment revenues of $289.7 million were up more than 100% from the year-ago quarter. The uptick was driven by the buyout of citizen engagement centers, revenues from which totaled $176 million.
Outside U.S. segment revenues of $156 million decreased 18% year over year on a reported basis and 12% on a constant currency basis due to decreases in welfare-to-work contracts in the United Kingdom and Australia.
Year-to-date signed contract awards at Mar 31, 2019 totaled $1 billion and contracts pending (awarded but unsigned) totaled $725 million.
The sales pipeline at Mar 31, 2019, was $21.9 billion. This included roughly $1.3 billion in proposals pending, $2.5 billion in proposals in preparation and $18.1 billion in opportunities tracking.
Operating Performance
Operation income of $81.8 million declined 14.7% year over year. Operating margin of 11.1% declined 50 basis points (bps).
Balance Sheet and Cash Flow
The company ended the quarter with cash and cash equivalents balance of $46.8 million compared with $54.7 million in the prior quarter. Long-term debt at the end of the quarter was $120.3 million.
The company generated $67.9 million of cash from operating activities and capex was $8.6 million. Free cash flow at the end of the quarter was $59.3 million.
Share Repurchase and Dividend Payout
MAXIMUS repurchased shares for $5.1 million and paid dividends of $16 million during the reported quarter.
Outlook
MAXIMUS narrowed its fiscal 2019 earnings and revenue guidance. It now expects earnings per share in the range of $3.65 to $3.75, compared with the previous guidance of $3.55-$3.75. The Zacks Consensus Estimate is pegged at $3.72.
The company expects revenues between $2.925 billion and $2.950 billion, compared with the previous guidance of $2.925-$3.0 billion. The Zacks Consensus Estimate is pegged at $2.96 billion.
Long-term expected EPS (three to five years) growth rate for WEX, Navigant Consulting and FLEETCOR is 15%, 13.5% and 16.5%, respectively.
Zacks' Top 10 Stocks for 2019
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-holds for the year?
Who wouldn't? Our annual Top 10s have beaten the market with amazing regularity. In 2018, while the market dropped -5.2%, the portfolio scored well into double-digits overall with individual stocks rising as high as +61.5%. And from 2012-2017, while the market boomed +126.3, Zacks' Top 10s reached an even more sensational +181.9%.
Image: Bigstock
MAXIMUS (MMS) Beats on Q2 Earnings, Narrows 2019 Guidance
MAXIMUS, Inc. (MMS - Free Report) reported mixed second-quarter fiscal 2019 results, with earnings beating the Zacks Consensus Estimate but revenues lagging the same.
Earnings per share came in at $1.07 compared with 82 cents reported in the year-ago quarter. The bottom line beat the consensus mark by 15 cents and was benefited by strong performance of the U.S. Health and Human Services, and U.S. Federal Services Segments.
Revenues of $736.5 million missed the consensus mark by $30 million but improved 20% year over year, mainly driven by the acquisition of citizen engagement centers in the U.S. Federal Services Segment.
At the call, management stated that the company continues to execute on its three-pronged strategy of digital transformation, clinical evolution and market expansion.
MAXIMUS shares have gained 12% year to date, significantly underperforming the 25.3% rally of the industry it belongs to.
Revenues by Segment
U.S. Health and Human Services segment revenues of $290.7 million decreased 5% year over year mainly due to the rebid or extension of certain larger contracts in the portfolio.
U.S. Federal Services segment revenues of $289.7 million were up more than 100% from the year-ago quarter. The uptick was driven by the buyout of citizen engagement centers, revenues from which totaled $176 million.
Outside U.S. segment revenues of $156 million decreased 18% year over year on a reported basis and 12% on a constant currency basis due to decreases in welfare-to-work contracts in the United Kingdom and Australia.
Maximus, Inc. Revenue (TTM)
Maximus, Inc. revenue-ttm | Maximus, Inc. Quote
Salas and Pipeline
Year-to-date signed contract awards at Mar 31, 2019 totaled $1 billion and contracts pending (awarded but unsigned) totaled $725 million.
The sales pipeline at Mar 31, 2019, was $21.9 billion. This included roughly $1.3 billion in proposals pending, $2.5 billion in proposals in preparation and $18.1 billion in opportunities tracking.
Operating Performance
Operation income of $81.8 million declined 14.7% year over year. Operating margin of 11.1% declined 50 basis points (bps).
Balance Sheet and Cash Flow
The company ended the quarter with cash and cash equivalents balance of $46.8 million compared with $54.7 million in the prior quarter. Long-term debt at the end of the quarter was $120.3 million.
The company generated $67.9 million of cash from operating activities and capex was $8.6 million. Free cash flow at the end of the quarter was $59.3 million.
Share Repurchase and Dividend Payout
MAXIMUS repurchased shares for $5.1 million and paid dividends of $16 million during the reported quarter.
Outlook
MAXIMUS narrowed its fiscal 2019 earnings and revenue guidance. It now expects earnings per share in the range of $3.65 to $3.75, compared with the previous guidance of $3.55-$3.75. The Zacks Consensus Estimate is pegged at $3.72.
The company expects revenues between $2.925 billion and $2.950 billion, compared with the previous guidance of $2.925-$3.0 billion. The Zacks Consensus Estimate is pegged at $2.96 billion.
Zacks Rank & Stocks to Consider
MAXIMUS currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader Zacks Business Services sector are WEX (WEX - Free Report) , Navigant Consulting (NCI - Free Report) and FLEETCOR Technologies . While WEX and Navigant Consulting (NCI - Free Report) sport a Zacks Rank #1 (Strong Buy), FLEETCOR carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Long-term expected EPS (three to five years) growth rate for WEX, Navigant Consulting and FLEETCOR is 15%, 13.5% and 16.5%, respectively.
Zacks' Top 10 Stocks for 2019
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-holds for the year?
Who wouldn't? Our annual Top 10s have beaten the market with amazing regularity. In 2018, while the market dropped -5.2%, the portfolio scored well into double-digits overall with individual stocks rising as high as +61.5%. And from 2012-2017, while the market boomed +126.3, Zacks' Top 10s reached an even more sensational +181.9%.
See Latest Stocks Today >>